SUITE 200, 1920 YONGE STREET, TORONTO, A6
Strengthens Board with Appointment of Slanix Paul Alex, Pharm.D., President and Portfolio Manager, Public Equity of Ally Bridge Group
News, Material Contracts
Receives DSMB Approval to Advance to Final Dose Escalation Cohort in Phase 1b Alzheimer’s Trial of PMN310
Material Contracts
Announces Second Quarter 2025 Financial Results & Corporate Highlights
Announces Private Placement Financing
Material disclosure
Q2
Q1
FY 2024
FY 2023
Q3
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership